4th-IR
4th-IR's Overview
4th-IR specializes in developing and deploying artificial intelligence (AI) and machine learning (ML) solutions tailored for the life sciences sector. The company aims to accelerate scientific discovery, enhance drug development pipelines, and improve patient outcomes by leveraging cutting-edge data analytics. Their services cater to pharmaceutical companies, biotech firms, and research institutions, helping them unlock insights from complex biological data.
Where is 4th-IR's Headquarters?
HQ Function
Serves as the central hub for research and development, strategic planning, and administrative operations, fostering collaboration among its core team of AI specialists and bioinformaticians.
Notable Features:
Located in a modern business park, offering a collaborative workspace designed to foster innovation in AI and life sciences. Specific architectural details are not widely publicized, typical for an office suite in a larger complex.
Work Culture:
Emphasizes a culture of innovation, scientific rigor, and collaboration. Being a specialized AI firm, it likely fosters a dynamic, research-oriented environment with a focus on problem-solving and cutting-edge technology.
HQ Significance:
Strategically positioned in the San Francisco Bay Area, providing access to a rich ecosystem of technology talent, biotech companies, and research institutions, crucial for its focus on AI in life sciences.
Values Reflected in HQ: The headquarters' location and setup likely reflect values of innovation, efficiency, and strategic positioning within a key technological and biotech hub.
Location:
While headquartered in California, 4th-IR's solutions and collaborations in the life sciences sector inherently have a global reach, supporting research and development efforts for international clients and partners. Their AI platforms can be accessed and utilized by organizations worldwide.
Street Address:
5994 W Las Positas Blvd, Suite 211
City:
Pleasanton
State/Province:
CA
Country:
USA
4th-IR's Global Presence
Buying Intent Signals for 4th-IR
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of 4th-IR
As of April 2025, 4th-IR' leadership includes:
Investors of 4th-IR
4th-IR has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
No major public announcements regarding executive hires or exits have been identified for 4th-IR in the last 12 months. The core leadership team appears stable.
Technology (Tech Stack) used by 4th-IR
Discover the tools 4th-IR uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
4th-IR Email Formats and Examples
Common email formats for technology companies like 4th-IR include [first_initial][last]@4th-ir.com (e.g., jdoe@4th-ir.com) or [first].[last]@4th-ir.com (e.g., jane.doe@4th-ir.com). The exact format(s) used by 4th-IR are not publicly confirmed but these are common patterns.
[first_initial][last]@4th-ir.com or [first].[last]@4th-ir.com
Format
jdoe@4th-ir.com or jane.doe@4th-ir.com
Example
75%
Success rate
News and media
4th-IR Website Insights • April 18, 2024
4th-IR CEO Discusses Navigating the Regulatory Landscape for AI-Driven Drug Discovery
Dr. Thomas Wingert, CEO of 4th-IR, shared insights on the evolving regulatory considerations for AI in drug discovery and development, emphasizing the need for robust validation and transparency in AI model development to ensure safety and efficacy....more
4th-IR Website Insights • February 15, 2024
4th-IR Explores the Role of Generative AI in Accelerating Drug Discovery
4th-IR published an article detailing how generative AI technologies are being leveraged to speed up various stages of drug discovery, from target identification to molecule design, highlighting potential breakthroughs....more
Outsourcing-Pharma.com • March 28, 2023
4th-IR CEO Highlights AI's Transformative Role in Drug Discovery and Development
In an interview with Outsourcing-Pharma, 4th-IR's CEO, Thomas Wingert, discussed the significant impact of artificial intelligence on accelerating timelines and improving success rates in pharmaceutical research and development....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including 4th-IR, are just a search away.